| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | SVP, Operations
1 company
Jung Cassie is a Chief Operating Officer at Aquestive Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $807K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | AQST Aquestive Therapeutics, Inc. | Chief Operating Officer | Sell | 45,791 | $4.17 | $191,085.84 | -14.3% | -6.4% | - | |
| Oct 15, 2025 | AQST Aquestive Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 67,575 | $7.01 | $473,700.75 | -21.9% | -53.4% | - | |
| Sep 4, 2025 | AQST Aquestive Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 62,180 | $5.00 | $310,900.00 | -18.0% | +21.5% | - | |
| Nov 26, 2024 | AQST Aquestive Therapeutics, Inc. | Chief Operating Officer | Sell | 44 | $4.87 | $214.06 | -100% | -39.2% | +27.5% |